Company | Name | Exchange | Sector | Industry | 3 Month | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dominari Holdings | NASDAQ | Financials | Investment Banking & Investment Services | 255.2% | $68.09M | -1.3x | -0.19 | $4.78 | -8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Gorilla Tech | NASDAQ | Technology | Software & IT Services | 80.2% | $469.74M | 3.2x | 0.18 | $25.04 | -1.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25% Upside | Upgrade to Pro+ | |
EverQuote A | NASDAQ | Technology | Software & IT Services | 62.2% | $960.26M | 29.3x | 0.2 | $26.88 | -4.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21% Upside | Upgrade to Pro+ | |
SANUWAVE | OTC Markets | Healthcare | Healthcare Equipment & Supplies | 60% | $318.69M | -298.2x | -0.24 | $37.28 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SANUWAVE Health | NASDAQ | 60% | $318.69M | -298.2x | -0.24 | $36.55 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
DBV Technologies | NASDAQ | Healthcare | Pharmaceuticals | 51.4% | $119.96M | -1.1x | -1.6 | $6.20 | 53.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BeiGene ADS | NASDAQ | Healthcare | Biotechnology & Medical Research | 41.8% | $28.24B | -44.4x | -1.53 | $267.39 | 1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.5% Upside | Upgrade to Pro+ | |
Exodus Movement | NYSE | 41.3% | $1.50B | 7.4x | 0.02 | $47.84 | -8.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.5% Downside | Upgrade to Pro+ | |||
Pinetree Capital | OTC Markets | Financials | Investment Banking & Investment Services | 39.7% | $92.44M | 4.1x | 0.01 | $10 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
TriSalus Life Sciences | NASDAQ | Healthcare | Biotechnology & Medical Research | 36.6% | $170.15M | -4.2x | -0.04 | $5.62 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
SpringWorks | NASDAQ | Healthcare | Biotechnology & Medical Research | 33.5% | $3.55B | -13.6x | -0.45 | $47.41 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
LandBridge Co LLC | NYSE | Energy | Oil & Gas | 31.9% | $5.83B | 310.5x | $69.69 | -8.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.2% Upside | Upgrade to Pro+ | ||
Protagonist Therapeutics | NASDAQ | Healthcare | Biotechnology & Medical Research | 29.7% | $3.01B | 11x | 0.03 | $48.88 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 39.6% Upside | Upgrade to Pro+ | |
CorMedix | NASDAQ | Healthcare | Pharmaceuticals | 29.6% | $436.39M | -21.6x | -2.48 | $6.73 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hims Hers Health | NYSE | Healthcare | Healthcare Providers & Services | 25.9% | $6.46B | 49.8x | 0.11 | $29.14 | -8.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.2% Upside | Upgrade to Pro+ | |
BridgeBio Pharma | NASDAQ | Healthcare | Pharmaceuticals | 25.2% | $6.69B | -12.3x | -0.46 | $35.10 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 40.1% Upside | Upgrade to Pro+ | |
Himalaya Shipping | NYSE | Industrials | Freight & Logistics Services | 24.4% | $273.56M | 12.2x | 0.01 | $5.82 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 49.9% Upside | Upgrade to Pro+ | |
Tetragon | OTC Markets | Financials | Collective Investments | 22.7% | $1.23B | 3.6x | $14.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Nanobiotix | NASDAQ | Healthcare | Biotechnology & Medical Research | 21.5% | $171.13M | -4.3x | -0.09 | $3.61 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Two Harbors | NYSE | Real Estate | Residential & Commercial REITs | 21.5% | $1.37B | 5.5x | 0.02 | $13.21 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.1% Upside | Upgrade to Pro+ | |
Two | NYSE | Real Estate | Real Estate Operations | 21.5% | $947.64M | 3.9x | 0.02 | $9.11 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 47.1% Upside | Upgrade to Pro+ | |
Anterix | NASDAQ | Technology | Telecommunications Services | 21.4% | $666.71M | -22.1x | 0.08 | $35.74 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Mesabi Trust | NYSE | Basic Materials | Metals & Mining | 20.9% | $354.37M | 3.8x | 0.01 | $26.95 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Delcath Systems | NASDAQ | Healthcare | Healthcare Equipment & Supplies | 19.9% | $438.42M | -14.1x | -0.25 | $13.15 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
51Talk Online Education DRC | NYSE | Academic & Educational Services | Miscellaneous Educational Service Providers | 19.2% | $119.17M | -15.9x | -0.3 | $21.01 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Annaly Capital Management | NYSE | Real Estate | Residential & Commercial REITs | 18.6% | $11.93B | 12.7x | 0.1 | $20.66 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -0.4% Downside | Upgrade to Pro+ | |
Robinhood Markets | NASDAQ | Technology | Financial Technology (Fintech) & Infrastructure | 18.3% | $38.95B | 26.1x | 0.08 | $41.92 | -4.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rigel | NASDAQ | Healthcare | Pharmaceuticals | 17.8% | $319.39M | 18x | 0.12 | $17.86 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.8% Upside | Upgrade to Pro+ | |
Gold Royalty | NYSE | Financials | Investment Banking & Investment Services | 17.1% | $245.65M | -69x | -0.77 | $1.44 | -3.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Krystal Biotech | NASDAQ | Healthcare | Biotechnology & Medical Research | 16.4% | $5.32B | 59x | 0.09 | $183.51 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18.5% Upside | Upgrade to Pro+ | |
Dynex Capital | NYSE | Real Estate | Residential & Commercial REITs | 16.4% | $1.20B | 8.7x | 0.02 | $13.05 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 4.5% Upside | Upgrade to Pro+ | |
Sprott Physical Gold and Silver Trust | NYSE | Financials | Collective Investments | 15.3% | $5.63B | 5.7x | $28.08 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Authid | NASDAQ | Technology | Software & IT Services | 15.3% | $69.68M | -4.8x | -0.1 | $6.48 | 2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
InterDigital | NASDAQ | Technology | Communications & Networking | 14.6% | $5.40B | 14.9x | 0.27 | $210.04 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2.3% Upside | Upgrade to Pro+ | |
Clearside Biomedical | NASDAQ | Healthcare | Biotechnology & Medical Research | 14.2% | $75.09M | -2.1x | -0.09 | $0.95 | -7.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
DeFi Tech | OTC Markets | Technology | Financial Technology (Fintech) & Infrastructure | 14.2% | $890.27M | 11x | 0.06 | $2.51 | -7.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Arcutis | NASDAQ | Healthcare | Biotechnology & Medical Research | 13.6% | $1.86B | -13.4x | -0.21 | $15.73 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 21.2% Upside | Upgrade to Pro+ | |
Global Net Lease | NYSE | Real Estate | Residential & Commercial REITs | 13.4% | $1.83B | -10.4x | -0.19 | $8 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.2% Upside | Upgrade to Pro+ | |
KKR Real Estate | NYSE | Real Estate | Residential & Commercial REITs | 12.8% | $766.16M | 58x | 0.48 | $10.94 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 16.6% Upside | Upgrade to Pro+ | |
Mirum Pharmaceuticals | NASDAQ | Healthcare | Biotechnology & Medical Research | 12.7% | $2.26B | -24.9x | -0.49 | $45.99 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 41.1% Upside | Upgrade to Pro+ | |
AGNC Invest | NASDAQ | Real Estate | Residential & Commercial REITs | 11.6% | $8.54B | 10.2x | 0.01 | $9.53 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 6.3% Upside | Upgrade to Pro+ | |
Invesco Mortgage | NYSE | Real Estate | Residential & Commercial REITs | 10.9% | $487.66M | 12.3x | 0.09 | $7.93 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -2.1% Downside | Upgrade to Pro+ | |
ARS Pharmaceuticals | NASDAQ | Healthcare | Biotechnology & Medical Research | 10.4% | $1.23B | 150.6x | 1.33 | $12.48 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Orchid Island Capital | NYSE | Real Estate | Residential & Commercial REITs | 10% | $713.23M | 13.3x | 0.12 | $7.66 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.2% Upside | Upgrade to Pro+ | |
Ascentage Pharma | NASDAQ | 7.6% | $1.76B | -27.9x | -0.53 | $21.65 | 7.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.6% Upside | Upgrade to Pro+ | |||
Fennec Pharma | NASDAQ | Healthcare | Biotechnology & Medical Research | 7.4% | $178.26M | -404.2x | -26.12 | $6.50 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Guild | NYSE | Financials | Banking Services | 6.6% | $990.46M | 9.8x | 0.03 | $15.93 | 17% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.8% Upside | Upgrade to Pro+ | |
Vinacapital Vietnam | OTC Markets | Financials | Collective Investments | 6.1% | $785.50M | 10.1x | $5.60 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Nexpoint Real Estate Finance | NYSE | Real Estate | Residential & Commercial REITs | 4.9% | $350.66M | 15.3x | 0.03 | $24.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Scottish Mortgage | OTC Markets | Financials | Collective Investments | 4.9% | $15.08B | 6.7x | 0.02 | $12.43 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |